Phthalate exposure in pregnant women and their children in central Taiwan

Susana Lin1, Hsiu-Ying Ku, Pen-Hua Su

  • 1National Health Research Institutes, Taiwan. susanalin@nhri.org.tw

Chemosphere
|November 16, 2010
PubMed

Insights

Phthalate exposure is higher in Taiwanese children than pregnant women, with DEHP metabolites most common. Further research is needed on DEHP and DiNP health effects in children.

Area of Science:

  • Environmental Health
  • Toxicology
  • Pediatrics

Background:

  • Phthalate exposure is linked to endocrine disruption and developmental toxicity.
  • Increased plastic use may elevate phthalate exposure in Taiwan, especially for children.
  • Urgent need to assess phthalate exposure levels and health impacts in vulnerable populations.

Purpose of the Study:

  • To quantify phthalate metabolite levels in pregnant women, newborns, and children in Taiwan.
  • To compare exposure levels across different age groups and sample types (urine, cord blood, milk).
  • To investigate correlations between maternal and infant phthalate exposure.

Main Methods:

  • Prospective cohort study in Central Taiwan.
  • Analysis of 11 phthalate metabolites in urine, cord serum, and breast milk samples.
  • Statistical analysis including excretion factors and correlation analysis.

Main Results:

  • Higher urinary phthalate metabolite concentrations in 2- and 5-year-old children compared to pregnant women.
  • Di(isononyl) phthalate (DiNP) metabolite proportion was significantly higher in children's urine.
  • Phthalate levels in cord blood and milk were relatively low and comparable to global levels, with a correlation between maternal urine and cord blood DEHP metabolites.

Conclusions:

  • Taiwanese children exhibit higher phthalate exposure than pregnant women, particularly from DEHP and DiNP.
  • Maternal urinary DEHP metabolite levels correlate with cord blood levels.
  • Further investigation into the health effects of DEHP and DiNP exposure in children is warranted.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...